囊袋栓塞与肠系膜下动脉栓塞预防EVAR后II型内漏的比较
该研究比较了囊袋栓塞(SACE)与肠系膜下动脉栓塞(IMAE)在EVAR术后高危患者中预防持续性II型内漏(pT2EL)和促进瘤囊缩小的效果。纳入75例IMA通畅且T2EL高危患者,SACE组42例,IMAE组33例。结果显示SACE组pT2EL发生率显著更低(2.4% vs 21.2%),瘤囊缩小率更高(83.3% vs 57.6%),且造影剂用量更少。
要点
- SACE较IMAE显著降低pT2EL发生率(2.4% vs 21.2%)。
- SACE组瘤囊缩小率更高(83.3% vs 57.6%)。
- SACE造影剂用量更少,安全性相当。
核心结论
- 在高危EVAR患者中,SACE比IMAE更有效地预防pT2EL并促进瘤囊缩小。
主要发现
- SACE组pT2EL发生率为2.4%,IMAE组为21.2%(p=0.007;HR:0.140,95%CI:0.034-0.578)。
- SACE组瘤囊缩小(>5 mm)率为83.3%,IMAE组为57.6%(p=0.005;HR:2.272,95%CI:1.286-4.014)。
- 瘤囊增大(>5 mm)仅见于IMAE组(6.1%,p=0.097)。
- SACE组造影剂用量更少(113.7 ± 24.5 vs 140.5 ± 29.6 mL,P < 0.001)。
- 两组均无破裂或AAA相关死亡。
临床怎么用
- 对于IMA通畅且T2EL高风险的EVAR患者,可优先考虑SACE作为辅助栓塞策略。
局限性
- 需要多中心、更长随访的研究来确认获益并优化技术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the efficacy of sac embolization (SACE) versus inferior mesenteric artery embolization (IMAE) in preventing persistent Type II endoleaks (pT2EL) and promoting aneurysmal sac shrinkage following endovascular aneurysm repair (EVAR) in high-risk patients. METHODS: From January 2018 to December 2022, 273 EVAR patients were screened, and 75 with patent IMA and high T2EL risk were included. Patients were divided into 2 groups: EVAR with IMAE (33 cases) and EVAR with SACE (42 cases). The primary endpoint was the incidence of pT2EL. Secondary endpoints included sac enlargement, shrinkage, and T2EL-related reintervention. Kaplan-Meier analysis and multivariate regression were used for comparisons. RESULTS: SACE was associated with a significantly lower incidence of pT2EL than IMAE (2.4% vs 21.2%, p=0.007; HR: 0.140, 95% CI: 0.034-0.578) and a higher rate of sac shrinkage (>5 mm reduction) (83.3% vs 57.6%, p=0.005; HR: 2.272, 95% CI: 1.286-4.014). Sac enlargement (>5 mm) occurred only in the IMAE group (6.1%, p=0.097). SACE required less contrast use (113.7 ± 24.5 vs 140.5 ± 29.6 mL, P < 0.001) and exhibited a trend toward fewer reinterventions. No ruptures or AAA-related deaths occurred in either group. CONCLUSION: SACE is more effective than IMAE in preventing pT2EL and promoting sac shrinkage in high-risk EVAR patients. These results support SACE as the preferred adjunctive strategy, warranting further multicenter studies with longer follow-up to confirm its benefits and optimize techniques.Clinical ImpactThis study provides comparative evidence on two adjunctive techniques used during EVAR for high-risk patients. Sac embolization (SACE) demonstrated a lower incidence of persistent type II endoleaks and a higher rate of aneurysm sac shrinkage compared with inferior mesenteric artery embolization (IMAE), with reduced contrast use and comparable safety. These findings suggest that SACE may offer a more effective and practical approach for type II endoleak prevention and sac regression, potentially improving long-term outcomes and procedural efficiency in EVAR practice.
引用
- Zhao Y, Liu F, Fu J, et al. Comparing Sac Embolization and Inferior Mesenteric Artery Embolization in Preventing Type II Endoleaks Post-EVAR. J Endovasc Ther. 2025. PMID: 41195690. doi:10.1177/15266028251388729
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。